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Purpose and Importance: Corynebacterium macginleyi, a lipophilic diphtheroid from the genus Cor-
ynebacteria, is a known cause of conjunctivitis. It was recently reported as a cause of serious infections in
immunocompromised individuals. It has never been reported as a cause of ventilator-associated pneu-
monia, that which carries a high burden and risk of mortality. Our report intends to increase awareness
of a potentially lethal nosocomial bacterial infection.
Observations: This case reports on a 73 year old lady with metastatic lung adenocarcinoma on chemo-
therapy, who was hospitalized for dyspnea and diffuse pulmonary inﬁltrates in 2011. Trans-bronchial
biopsies revealed cryptogenic organizing pneumonia. The patient improved with steroids. Failure to
wean ensued with a bronchopleural ﬁstula, increase in secretions, oxygen requirements, and appearance
of new inﬁltrates. Two mini-BAL cultures yielded gram positive pleomorphic rods with palisade
arrangement, diagnosed as C. macginleyi. Vancomycin therapy was initiated. She improved and was
successfully extubated.
Conclusion and relevance: Non-diphtheria Corynebacteria usually form normal ﬂora. If isolated, they are
often dismissed as contaminants. C. macginleyi has emerged as a life-threatening nosocomial infection.
Prompt identiﬁcation and treatment are required. It is resistant to quinolones. Thus far, vancomycin is the
preferred treatment.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The Corynebacterium species are aerobic gram positive pleo-
morphic rods. The most important for human health is Coryne-
bacterium diphtheriae, the pathogen chieﬂy responsible for
diphtheria. The majority of Corynebacterium species are innocuous
and ubiquitous in nature. Some can be found on mucosa or on skin
in humans. When isolated from clinical samples, past practice
habits had been to consider them as contaminants. However, there
have been reports of non-diphtheria Corynebacteria causing
nosocomial infections in certain at-risk populations, such as
immunocompromised patients, or those with indwelling devices
[1].
Among these is Corynebacterium macginleyi, ﬁrst described in
1995 by Riegel et al. and named in honor of Kenneth John McGinley
[2]. It is a lipophilic diphtheroid [3] that has been mainly isolatedLtd. This is an open access article ufrom ocular samples in conjunctivitis [4,5]. More recently, there
have been reports of non-ocular infections: a urinary tract infection
associated with an indwelling bladder catheter [6], an intravenous
catheter-related blood-stream infection [7], a case of septicemia [8],
a case of endocarditis [9], a case of pneumonia in an HIV infected
individual [10], a tracheostomy site infection in a patient with
laryngeal carcinoma [11], and a case of surgical site infection
following orthopedic surgery [12].
We hereby report a case of C. macginleyi as an emerging cause of
ventilator-associated pneumonia in an immunocompromised
individual.
2. Case report
A 73-year-old lady with a 40-pack-year smoking history, COPD
and metastatic left lung adenocarcinoma, recently treated with
erlotinib, gemcitabine and radiation therapy, was admitted for
progressive dyspnea. A PET/CT Scan showed interval decrease in
the lung mass (indicating a partial response to therapy), but in-
terval development of diffuse bilateral (right greater than left)nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. Light microscopy of BAL specimen showing the organism in palisade
arrangement.
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thought to be related to an atypical infection, an inﬂammatory
process, or acute interstitial pneumonitis. Levoﬂoxacin, cefepime
and vancomycin were started after cultures were sent, and later
showed no growth. The patient's condition deteriorated, resulting
in hypoxemic respiratory failure and mechanical ventilation. She
underwent bronchoscopy, transbronchial biopsy and bron-
choalveolar lavage (BAL). The procedure was complicated by a
right-sided pneumothorax, for which a chest tube was placed. Pa-
thology showed a cryptogenic organizing pneumonia, likely related
to erlotinib. Cultures were negative. Prednisone was started,
resulting in clinical improvement. However the patient remained
intubated due to persistence of the pneumothorax with formation
of a broncho-pleural ﬁstula. Furthermore, she developed zoster
which subsequently resolved with acyclovir.
While still intubated, there was an increase in secretions and
oxygen requirements with leukocytosis. A chest X ray showed a
new right middle lobe inﬁltrate (Fig. 1). A mini-BAL was submitted
for culture and incubated for 24 h at 37 C on 5% sheep blood agar
and chocolate agar. Microscopic examination showed a few
epithelial cells, many polymorphonuclear cells, and many gram
positive rods in palisade arrangement (Fig. 2). The culture grew
more than 105 of the lipophilic bacterium C. macginleyi solely,
further identiﬁed with a 99.3% probability using the API Coryne
System V3.0 (proﬁle number 1100305; bioMerieux, France).
Sensitivity testing was performed using the Etest, revealing sus-
ceptibility to vancomycin, but resistance to penicillins, cephalo-
sporins and quinolones. These results were initially thought to
represent contamination. No antibiotics were started. However, in
view of continued worsening of the patient's respiratory status,
another mini-BAL culture was sent two days later, yielding the
same results. Hence a ten-day course of vancomycin was given and
the patient improved clinically and radiographically. A subsequent
mini-BAL culture, following the vancomycin course, was negative.
The patient underwent a tracheotomy, was successfully weaned off
of mechanical ventilation and was discharged to an extended-care
facility.3. Discussion
Ventilator associated pneumonias can be hard to treat, partic-
ularly in the immunocompromised host. They are an immenseFig. 1. Chest X ray showing the new right lung inﬁltrate.burden on healthcare resources and a major cause of death.
C. macginleyi, a gram positive pleomorphic rod is a normal inhab-
itant of mucous membranes. Although it had often been dismissed
as a non-pathogenic contaminant, C. macginleyi has been more
recently implicated in several cases of systemic infections.
Furthermore, more recent and accurate identiﬁcation methods
using rpoB gene sequencing [13] have been enacted to improve
detection (this was not available at our facility when this organism
was discovered). This test separates C. macginleyi from Corynebac-
terium accolens with 100% certainty.
Nonetheless, neither C. macginleyi nor C. accolens has been re-
ported as a cause of ventilator associated pneumonia in an
immunocompromised host. A prior report demonstrated that
C. macginleyi can cause pneumonia in individuals with HIV and
advanced AIDS [10]. Another account implicated C. macginleyi as a
cause of tracheostomy infection in a patient with laryngeal cancer
[11]. In our patient, risk factors were lung cancer, prior treatment
with chemotherapy and high dose steroids, radiation as well as
lung inﬂammation from cryptogenic organizing pneumonia. To
date, reports of ophthalmologic isolates have exhibited a high level
resistance to antibiotics commonly used in the treatment of res-
piratory infections. For example high-level ﬂuoroquinolone resis-
tance has been seen in ophthalmic isolates [14], as well as in non-
ocular cases [10]. The strain isolated in a previously reported uri-
nary catheter-related infection was only sensitive to vancomycin,
netilmycin and tetracycline [6]. In all the reported cases
C. macginleyi has been sensitive to vancomycin while variably
resistant to other antibiotics. In our account, the organism was
exclusively sensitive to vancomycin, however it was not tested
against linezolid or daptomycin.
The growing number of non-ocular infections with C. macginleyi
in immunocompromised patients suggests this pathogen might be
destined to be increasingly implicated in life-threatening in-
fections. Therefore, rapidly dismissing it as a contaminant could be
dangerous. In the absence of an alternative diagnosis, positive
cultures from adequate samples in the appropriate host should be
taken seriously and treatment should be promptly initiated. Given
the limited data available in the literature, we recommend initi-
ating therapy with vancomycin, and readjusting after susceptibility
results become available.Contributions
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